Analysis of ADAM17 polymorphisms and susceptibility to sporadic abdominal aortic aneurysm

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1426-1438

  Li, You ^a   Yang, Cheng ^b   Ma, Guoda ^a   Cui, Lili ^a   Gu, Xuefeng ^a   Chen, Yanyan ^a   Zhao, Bin ^a   Wang, Haiyang ^c   Li, Keshen ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Abdominal aortic aneurysm; ADAM17; Polymorphism

Indexed keywords

ADAM17 PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADAM PROTEIN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ABDOMINAL AORTA ANEURYSM; ADAM17 GENE; ADULT; AGED; AORTA; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; RISK; SPORADIC ABDOMINAL AORTIC ANEURYSM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; VERY ELDERLY;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84900876761     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358708     Document Type: Article

References (41)

1. Zhang F, Kent KC, Yamanouchi D, Zhang Y, Kato K, Tsai S, Nowygrod R, Schmidt AM, Liu B: Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Sur g 2009;250:416-423.
2. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, Thompson MM: A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endo vasc Surg 2005;30:227-244. (Pubitemid 41086292)
3. Thompson MM, Jones L, Nasim A, Sayers RD, Bell PR: Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1996;11:464-469. (Pubitemid 26192856)
4. Zh ang J, Schmidt J, Ryschich E, Mueller-Schilling M, Schumacher H, Allenberg JR: Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J Vasc Surg 2003;38 :360-367. (Pubitemid 41123263)
5. Kadoglou NP, Liapis CD: Matrix metalloproteinases: Contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 2004;20:419-432. (Pubitemid 38525149)
6. Hinterseher I, Erdman R, Elmore JR, Stahl E, Pahl MC, Derr K, Golden A, Lillvis JH, Cindric MC, Jackson K, Bowen WD, Schworer CM, Chernousov MA, Franklin DP, Gray JL, Garvin RP, Gatalic a Z, Carey DJ, Tromp G, Kuivaniemi H: Novel pathways in the pathobiology of human abdominal aortic aneurysms. Pathobiology 2013;80:1-10.
7. Lindholt JS, Shi GP: Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2006;31:453-463.
8. Xiong W, MacTaggart J, Knispel R, Worth J, Persidsky Y, Baxter BT: Blocking tnf-alpha attenuates aneurysm formation in a murine model. J Immunol 2009;183:2741-2746.
9. Kaneko H, Anzai T, Horiuchi K, Kohno T , Nagai T, Anzai A, Takahashi T, Sasaki A, Shimoda M, Maekawa Y, Shimizu H, Yoshikawa T, Okada Y, Yozu R, Fukuda K: Tumor necrosis factor-alpha converting enzyme is a key mediator of abdominal aortic aneury sm development. Atherosclerosis 2011;218:470-478.
10. Dreymueller D, Pruessmeyer J, Groth E, Ludwig A: The role of adam-mediated shedding in vascular biology. Eur J Cell Biol 2012;91:472-485.
11. Canault M, Peiretti F, Kopp F, Bonardo B, Bonzi MF, Coudeyre JC, Alessi MC, Juhan-Vague I, Nalbone G: The tnf alpha converting enzyme (tace/adam17) is expressed in the atherosclerotic lesions of apolipoprotein e-deficient mice: Possible contribution to elevated plasma levels of soluble tnf alpha receptors. Atherosclerosis 2006;187:82-91. (Pubitemid 43833358)
12. Canault M, Peiretti F, Mueller C, Kopp F, Morange P, R ihs S, Portugal H, Juhan-Vague I, Nalbone G: Exclusive expression of transmembrane tnf-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis 2004;172:211-218. (Pubitemid 38167531)
13. Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A: Novel mechanisms of abdominal aortic aneurysms. Curr Atheroscler Rep 2012;14:402-412.
14. Wang M, Li Y, Lu Y, Zuo X, Wang F, Zhang Z, Jia J: The relationship between adam17 promoter polymorphisms and sporadic alzheimer's disease in a northern chinese han population. J Clin Neurosci 2010;17:1276-1279.
15. Junyent M Parnell LD Lai CQ Arnett DK Tsai MY Kabagambe EK Straka RJ Province M An P, Smith CE, Lee YC, Borecki I, Ordovas JM: Adam17-i33708a>g polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the genetics of lipid lowering drugs and diet network study Nutr Metab Cardiovasc Dis 2010 20 698-705.
16. Morange PE, Tregouet DA, Godefroy T, Saut N, Bickel C, Rupprecht HJ, Lackner K, Barbaux S, Poirier O, Peiretti F, Nalbone G, Juhan-Vague I, Blankenberg S, Tiret L: Polymorphisms of the tumor necrosis factor-alpha (tnf) and the tnf-alpha converting enzyme (tace/adam17) genes in relation to cardiovascular mortality: The atherogene study. J Mol Med (Berl) 2008;86:1153-1161.
17. Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Ge nsini GF, Abbate R, Giusti B: Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm. J Vasc Surg 2012;55:171-179 e172.
18. Armani C, Landi S, Nuti M, Di S tefano R, Balbarini A: Has-1 genetic polymorphism in sporadic abdominal aortic aneurysm. Heart Int 2009;4:e1.
19. Lipp C, Lohoefer F, Reeps C, Rudelius M, Baummann M, Heemann U, Eckstein HH, Pelisek J: Expression of a disintegrin and metalloprotease in human abdominal aortic aneurysms. J Vasc Res 2012;49:198-206.
20. Edwards DR, Handsley MM, Pennington CJ: The adam metalloproteinases. Mol Aspects Med 2008;29:258-289.
21. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. Journal of Clinical Investigation 2002;110:625-632. (Pubitemid 34988786)
22. Saftig P, Reiss K: The "a disintegrin and metalloproteases " adam10 and adam17: Novel drug targets with therapeutic potential Eur J Cell Biol 2011;90:527-535.
23. Elmore JR, Obmann MA, Kuivaniemi H, Tromp G, Gerhard GS, Franklin DP, Boddy AM, Carey DJ: Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide ass ociation. J Vasc Surg 2009;49:1525-1531.
24. Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, Den Heijer M, De Vries J-PP, Kranendonk SE, Zeebregts CJ, Van Sterkenburg SM, Geelkerken RH: Genome-wide association study identifies a sequence variant within the dab2ip gene conferring susceptibility to abdominal aortic aneurysm. Nature genetics 2010;42:692-697.
25. Bown MJ, Jones GT, Harrison SC, Wright BJ, Bumpstead S, Baas AF, Gretarsdottir S, Badger SA, Bradley DT, Burnand K, Child AH, Clough RE, Cockerill G, Hafez H, Scott DJ, Futers S, Johnson A, Sohrabi S, Smith A, Thompson M M, Van Bockxmeer FM, Waltham M, Matthiasson SE, Thorleifsson G, Thorsteinsdottir U, Blankensteijn JD, Teijink JA, Wijmenga C, De Graaf J, Kiemeney LA, Assimes TL, McPherson R, Folkersen L, Franco-Cer eceda A, Palmen J, Smith AJ, Sylvius N, Wild JB, Refstrup M, Edkins S, Gwilliam R, Hunt SE, Potter, Lindholt JS, Frikke-Schmidt R, Tybjaerg-Hansen A, Hughes AE, Golledge J, Norman PE, Van Rij A, Powell JT, Eriksson P, Stefansson K, Thompson JR, Humphries SE, Sayers RD, Deloukas P, Samani NJ: Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related prote in 1. Am J Hum Genet 2011;89:619-627.
26. Bjorck M, Wanhainen A: Pathophysiology of aaa: Heredity vs environment. Prog Cardiovasc Dis 2013;56:2-6.
27. Saratzis A, Abbas AA, Kiskinis D, Melas N, Saratzis N, Kitas GD: Abdominal aortic aneurysm: A review of the genetic basis. Angiology 2011;62:18-32.
28. Thompson AR, Drenos F, Hafez H, Humphries SE: Candidate gene association studies in abdominal aortic aneurysm disease: A review and meta-analysis. Eur J Vasc Endovasc Surg 2008;35:19-30. (Pubitemid 350235228)
29. Katz DJ, Stanley JC, Zelenock GB: Gender differences in abdominal aortic aneurysm prevalence, treatment, and outcome. J Vasc Surg 1997;25:561-568. (Pubitemid 27136982)
30. Laser A, Ghosh A, Roelofs K, Sadiq O, McEvoy B, Dimusto P, Eliason J, Upchurch GR, Jr.: Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males. J Surg Res 2014;186:467-474.
31. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G: Basal release o f nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc Natl Acad Sci U S A 1992;89:11259-11263.
32. Lederle FA, Nelson DB, Joseph AM: Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: A systematic review. J Vasc Surg 2003;38:329-334. (Pubitemid 41123258)
33. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT: Abdomin al aortic aneurysm expansion: Risk factors and time intervals for surveillance. Circulation 2004;110:16-21. (Pubitemid 38880128)
34. Jaldin RG, Castardelli E, Perobelli JE, Yoshida WB, De Castro Rodrigues A, Sequeira JL, Paiva SA: Morphologic and biomechanical changes of thoracic and abdominal aorta in a rat model of cigarette smoke exposure. Ann Vasc Surg 2013;27:791-800.
35. Stolle K Berges A Lietz M Lebrun S Wa llerath T Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin ii-treated apolipoprotein e-deficient mice Toxicol Lett 2010 199 403-409.
36. Li ZZ, Dai QY: Pathogenesis of abdominal aortic aneurysms: Role of nicotine and nicotinic acetylcholine receptors. Mediators Inflamm 2012;2012:103120.
37. Dollery CM, Libby P: Atherosclerosis and proteinase activation. Cardiovasc Res 2006;69:625-635. (Pubitemid 43139725)
38. Liu O, Jia L, Liu X, Wang Y, Wang X, Qin Y, Du J, Zhang H: Clopidogrel, a platelet p2y12 receptor inhibitor, reduces vascular inflammation and angiotensin ii induced-abdominal aortic aneurys m progression. PLoS One 2012;7:e51707.
39. Basu R, Fan D, Kandalam V, Lee J, Das SK, Wang X, Baldwin TA, Oudit GY, Kassiri Z: Loss of timp3 gene leads to abdominal aortic aneurysm forma tion in response to angiotensin ii. J Biol Chem 2012;287:44083-44096.
40. Smallwood L, Warrington N, Allcock R, Van Bockxmeer F, Palmer LJ, Iacopetta B, Golledge J, Norman PE: Matrix metall oproteinase-2 gene variants and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2009;38:169-171.
41. Wang J-A, Chen X-F, Yu W-F, Chen H, Liu X-M, Lin X-F, Tang L-J, Jiang J-J, Dong L, Jiang J: Prevalence of abdominal aortic aneurysms in chinese coronary artery disease patients. EJVES Extra 2008;15:37-38.